Bioimpedance Device Market: Overview
Lymphedema can be a major complication following significant medical interventions, such as mastectomy in women. To address this issue ImpediMed Ltd developed a bioimpedance technology for the early detection of lymphedema. The early detection of lymphedema can help surgeons to avoid the future complications which may arise after the mastectomy surgery. The companies L-DEX device is a FDA approved bioimpedance device to assess secondary unilateral lymphedema of the arm and leg in women, and the leg in men.
Bioimpedance Device Market: Region-wise Outlook
In terms of geography, bioimpedance device market has been divided into seven regions including North- America, Eastern Europe, Western Europe, Asia- Pacific excluding Japan, Japan Middle-East & Africa and Latin America.